Merrimack Pharmaceuticals, Inc.

Although U.S. stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Merrimack Pharmaceuticals The Trade: Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) Western Standard Partners QP LP acquired a total of 101,050 shares an average price of $12.85. To acquire these shares, it cost around $1.3 million. What’s Happening: On ...

Related tickers: TRMB, F, UNP, MACK.

Gainers Jounce Therapeutics, Inc. (NASDAQ: JNCE) shares rose 36.8% to $1.45 in pre-market after the company confirmed receipt of unsolicited proposal from Concentra Biosciences to acquire 100% of the company for $1.80 per share subject to diligence and availability of at least $130m of cash and equivalents at closing. HUB Cyber Security (Israel) Ltd. (NASDAQ: HUBC) rose 15.5% to $1.93 in pre-market trading after gaining more than 10% on Tuesday. HUB Security received $4 million from PIPE Investors at $10 per share. NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) rose 15.2% to $1.81 in pre-market trading after gaining around 5% on Tuesday. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) rose 14.1% to $3.49 in pre-market trading. Loyalty Ventures Inc. (NASDAQ: LYLT) rose 13.2% to $0.1924 in pre-market trading after dipping 23% on Tuesday. Smartsheet Inc. (NYSE: SMAR) rose 11.2% to $42.61 in pre-market trading after the company ...

Related tickers: LYLT, VCSA, LCI, TCBP, CS, HUBC, MACK, INBS, ELEV, KC, AMBI, CYAD, JNCE, INPX, NMTC, SMAR, ELYS, BOXD, QNRX.